Cleared Special

K071691 - DUAL SHOT ALPHA (FDA 510(k) Clearance)

Dec 2007
Decision
182d
Days
Class 2
Risk

K071691 is an FDA 510(k) clearance for the DUAL SHOT ALPHA. This device is classified as a Injector And Syringe, Angiographic (Class II - Special Controls, product code DXT).

Submitted by Nemoto Kyorindo Co., Ltd. (Laguna Hills, US). The FDA issued a Cleared decision on December 19, 2007, 182 days after receiving the submission on June 20, 2007.

This device falls under the Cardiovascular FDA review panel. Regulated under 21 CFR 870.1650.

Submission Details

510(k) Number K071691 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 20, 2007
Decision Date December 19, 2007
Days to Decision 182 days
Submission Type Special
Review Panel Cardiovascular (CV)
Summary Summary PDF

Device Classification

Product Code DXT - Injector And Syringe, Angiographic
Device Class Class II - Special Controls
CFR Regulation 21 CFR 870.1650